← Back to Clinical Trials
Recruiting NCT06904768

NCT06904768 Effect of Shoulder Sling Use on Balance and Mobility in Subacute Stroke Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06904768
Status Recruiting
Phase
Sponsor Arnaoutis Stylianos
Condition Hemiplegia
Study Type INTERVENTIONAL
Enrollment 17 participants
Start Date 2025-03-13
Primary Completion 2025-04

Trial Parameters

Condition Hemiplegia
Sponsor Arnaoutis Stylianos
Study Type INTERVENTIONAL
Phase N/A
Enrollment 17
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-03-13
Completion 2025-04
Interventions
Shoulder SlingNo Sling

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study examines whether wearing a shoulder sling can improve balance and mobility in people who are recovering from a stroke. Participants will perform simple movement and balance tests twice-once with the sling and once without. The goal is to find out if using the sling helps patients feel more stable and safe during walking and everyday activities.

Eligibility Criteria

Inclusion Criteria: * Clinical diagnosis of stroke in the subacute phase (up to 6 months post-onset) * Hemiplegia affecting one upper limb * Brunnstrom stage \< 4 for the affected upper limb * Functional Ambulation Category (FAC) score \> 3 * Age between 40 and 80 years * Ability to follow simple instructions * Medically stable to participate in balance and mobility testing * Signed informed consent Exclusion Criteria: * Severe cognitive impairment (e.g. MMSE \< 23) * Visual or vestibular disorders affecting balance * Significant orthopedic or musculoskeletal conditions of the lower limbs * Uncontrolled cardiovascular or pulmonary disease * Use of assistive devices that prevent sling application * Severe aphasia interfering with understanding or communication * Skin lesions or injuries at the shoulder region preventing sling use

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology